TI
Trexquant Investment’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,560
| Closed | -$305K | – | 1465 |
|
|
2022
Q3 | $305K | Buy |
+45,560
| New | +$305K | 0.01% | 1030 |
|
|
2021
Q2 | – | Sell |
-15,807
| Closed | -$443K | – | 1197 |
|
|
2021
Q1 | $443K | Buy |
+15,807
| New | +$443K | 0.04% | 563 |
|
|
2020
Q3 | – | Sell |
-16,092
| Closed | -$826K | – | 1282 |
|
|
2020
Q2 | $826K | Buy |
+16,092
| New | +$826K | 0.06% | 462 |
|
|
2019
Q3 | – | Sell |
-20,569
| Closed | -$957K | – | 927 |
|
|
2019
Q2 | $957K | Buy |
20,569
+6,166
| +43% | +$287K | 0.09% | 331 |
|
|
2019
Q1 | $578K | Buy |
14,403
+6,722
| +88% | +$270K | 0.04% | 549 |
|
|
2018
Q4 | $353K | Sell |
7,681
-11,438
| -60% | -$526K | 0.02% | 733 |
|
|
2018
Q3 | $848K | Buy |
+19,119
| New | +$848K | 0.06% | 395 |
|
|
2017
Q4 | – | Sell |
-16,591
| Closed | -$832K | – | 1095 |
|
|
2017
Q3 | $832K | Buy |
+16,591
| New | +$832K | 0.21% | 120 |
|
|
2016
Q4 | – | Sell |
-22,272
| Closed | -$308K | – | 1008 |
|
|
2016
Q3 | $308K | Buy |
+22,272
| New | +$308K | 0.07% | 469 |
|
|
2016
Q1 | – | Sell |
-50,800
| Closed | -$1.13M | – | 983 |
|
|
2015
Q4 | $1.13M | Sell |
50,800
-100
| -0.2% | -$2.23K | 0.1% | 342 |
|
|
2015
Q3 | $1.2M | Buy |
+50,900
| New | +$1.2M | 0.1% | 345 |
|